JNJ - Johnson & Johnson
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$250.58
DETAILS
HIGH:
$283.00
LOW:
$208.00
MEDIAN:
$252.50
CONSENSUS:
$250.58
UPSIDE:
6.93%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-01 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | F-InKind | 11,002 | $229.85 | $2.5M |
| 2026-05-01 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | M-Exempt | 25,255 | -- | -- |
| 2026-04-23 | MORIKIS JOHN G | director | A-Award | 1,540 | -- | -- |
| 2026-04-23 | McClellan Mark B. | director | A-Award | 975 | -- | -- |
| 2026-04-23 | HEWSON MARILLYN A | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Woods Eugene A. | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Doudna Jennifer A | director | A-Award | 975 | -- | -- |
| 2026-04-23 | WEINBERGER MARK A | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Joly Hubert | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Johnson Paula A | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Beckerle Mary C | director | A-Award | 975 | -- | -- |
| 2026-04-23 | West Nadja | director | A-Award | 975 | -- | -- |
| 2026-04-23 | Pinto Daniel E | director | A-Award | 1,712 | -- | -- |
| 2025-03-04 | HEWSON MARILLYN A | director | A-Award | 75 | -- | -- |
| 2026-03-10 | HEWSON MARILLYN A | director | A-Award | 206 | -- | -- |
| 2026-03-10 | Pinto Daniel E | director | A-Award | 129 | -- | -- |
| 2026-03-10 | Woods Eugene A. | director | A-Award | 154 | -- | -- |
| 2026-02-27 | Decker Robert J | officer: VP Corporate Controller | M-Exempt | 4,075 | $115.67 | $471K |
| 2026-02-27 | Decker Robert J | officer: VP Corporate Controller | SELL | 4,075 | $247.87 | $1.0M |
| 2026-02-20 | Schmid Timothy | officer: EVP, WW Chair, MedTech | SELL | 1,322 | $245.66 | $325K |
| 2026-02-15 | Swanson James D. | officer: EVP, CIO | M-Exempt | 492 | -- | -- |
| 2026-02-13 | Wolk Joseph J | officer: Exec VP, CFO | F-InKind | 15,948 | $244.55 | $3.9M |
| 2026-02-17 | Wolk Joseph J | officer: Exec VP, CFO | SELL | 24,961 | $242.68 | $6.1M |
| 2026-02-15 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | F-InKind | 270 | $243.45 | $66K |
| 2026-02-15 | Decker Robert J | officer: VP Corporate Controller | M-Exempt | 339 | -- | -- |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-05-13 | Ro Khanna | HOUSE | Purchase | $15,001 - $50,000 |
| 2026-04-14 | Thomas H. Kean | HOUSE | Sale | $1,001 - $15,000 |
| 2026-04-14 | John Boozman | SENATE | Sale | $1,001 - $15,000 |
| 2026-04-09 | Ro Khanna | HOUSE | Purchase | $1,001 - $15,000 |